Palestinian Medical and Pharmaceutical Journal Computational Design of Isatin–Sulfonamide Hybrids as Selective Carbonic Anhydrase XII Inhibitors with Anticancer Potential
Computational results present novel isatin-sulfonamide hybrids as promising candidates with moderate suggested selectivity, and predicted to be safe CA XII-inhibitor for further experimental development as an anticancer agent.
A network pharmacology analysis of compound 4d against pancreatic cancer identified 243 shared targets that converged, through protein-protein interactions and enrichment analyses, on the PI3K-AKT and receptor tyrosine kinase signalling axes, providing a system-level rationale for its anticancer potential.
S. Ejaz, M. Bilal, P. A. Channar et al.· RSC Advances· 0 citations
The multi‐target inhibition of two significant cancer drug targets, cathepsin B and human carbonic anhydrase (hCA) isoforms IX and XII has been explored. The exclusive synthesis of single isomeric structure of final compounds despite two possibilities, in vitro biological studies, in silico molecular docking, DFT and A...
Lalit Vats, Manishita Rani, Kiran Siwach et al.· Archiv der Pharmazie· 0 citations
A series of novel benzisothiazole‐based hydrazide derivatives was rationally designed, synthesized, and evaluated for their antitubercular activity. Among the synthesized compounds, derivative 8k emerged as the most potent candidate, exhibiting a minimum inhibitory concentration (MIC) of 0.25 μg/mL, along with a high s...
V. Sharma, Arun Sharma, Ruchi Poria et al.· Chemical Biology and Drug De...· 0 citations
OBJECTIVE
Aim: In this study, a series of novel aminocoumarin derivatives incorporating an amino-thiazole moiety were designed to evaluate their inhibitory activity against the carbonic anhydrase IX enzyme (PDB ID: 6fe0) and to explore their potential anti-neoplastic properties through molecular docking analysis.
PAT...
Alaa H. Fadel, Noor H. Naser· Polski merkuriusz lekarski :...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.